Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/AAC.01834-16

PubMed Identifier: 28438924

Publication URI: http://europepmc.org/abstract/MED/28438924

Type: Journal Article/Review

Volume: 61

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 7

ISSN: 0066-4804